Reducing brain injury, sensory damage following cardiac arrest

Those who have experienced cardiac arrest face long-term health effects related to brain activity. Recent research examined the impact of such events, including the deprivation of oxygen to the brain, and subsequent resuscitation efforts.

Led by Jason Middleton, PhD, assistant professor at Louisiana State University Health New Orleans School of Medicine, the study was published June 19 in eNeuro, the journal of the Society for Neuroscience.

The team examined hypoxic-ischemic brain injury resulting from cardiac arrest, which result in less responsive and less spatially tuned sensory cortical circuits.

Researchers examined 13 rats, measuring sensory response after oxygen deprivation after cardiac arrest. Following such events, sensory circuits in the brain were less responsive. The researchers concluded cardiac arrest and resuscitation will affect cortical circuit function.

"Our work characterizes the changes that occur in the sensory cortex after a form of global hypoxic injury in juvenile rats," wrote Middleton. "The injury did not result in widespread cell death as occurs in other forms of acute, focal ischemic injury; the deficits uncovered were subtler and reflected decreased ability of the cortex to discriminate sensory stimuli. We used computer modeling of the neural network to implicate changes in the balance of excitatory and inhibitory synaptic transmission in the cortex."

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.